Skip to main content
editorial
. 2020 Apr 15;35(4):335–337. doi: 10.1007/s10654-020-00628-1

Fig. 1.

Fig. 1

Renin–angiotensin system inhibition (RAS) by Angiotensin-converting enzyme/Ang-II receptor blockers (ACEI/ARBs) and SARS-CoV-2 binding to ACE2 receptors. Red squares indicate RAS actions, green squares indicate ACE actions. Black squares indicate effects for each component